Here are five insights:
1. Researchers analyzed 953 patients with stage III colon cancer during and 6 months after chemotherapy. Patients reported their intake of caffeinated coffee, decaffeinated coffee and non-herbal tea, as well as 128 other items.
2. Patients consuming four cups or more of coffee experienced an adjusted hazard ratio for colon cancer recurrence or mortality of 0.58, as compared with those who never drink coffee.
3. Patients consuming four cups or more of caffeinated coffee experienced significantly reduced cancer recurrence or mortality risk compared with abstainers.
4. Additionally, increasing caffeine intake also conferred a significant reduction in cancer recurrence or mortality.
5. Non-herbal tea and decaffeinated coffee did not impact patient outcome.
More articles on GI/endoscopy:
Exact Sciences’ price target hits $29
4 GI physicians in the news – Aug. 21, 2015
AGA proposes alternative to MOC recertification
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.